IQVIA
IQV
#885
Rank
NZ$47.18 B
Marketcap
NZ$277.10
Share price
-2.21%
Change (1 day)
-18.57%
Change (1 year)

Earnings for IQVIA (IQV)

Earnings in 2025 (TTM): NZ$3.98 Billion

According to IQVIA's latest financial reports the company's current earnings are NZ$15.90 Billion. In 2024 the company made an earning of NZ$3.91 Billion, an increase over its 2023 earnings that were of NZ$3.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IQVIA from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$3.98 B1.89%
2024 NZ$3.91 B9.76%
2023 NZ$3.56 B19.79%
2022 NZ$2.97 B18.36%
2021 NZ$2.51 B90.49%
2020 NZ$1.32 B-1.25%
2019 NZ$1.33 B7.68%
2018 NZ$1.24 B6.61%
2017 NZ$1.16 B11.74%
2016 NZ$1.04 B-2.79%
2015 NZ$1.07 B6.31%
2014 NZ$1.00 B34.96%
2013 NZ$0.74 B11.16%
2012 NZ$0.67 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.62 Million-100.09% Bahamas
NRC Health
NRC
NZ$46.13 M-98.80%๐Ÿ‡บ๐Ÿ‡ธ USA